• MicroVision, Inc. has already reported first-quarter 2026 results, with sales of US$935,000 versus US$589,000 a year earlier and a smaller net loss of US$25.29 million, while also closing a US$38.63 million shelf registration for additional common stock.

• A recent memorandum of understanding with Avular Innovations to integrate MicroVision’s solid-state lidar into modular autonomous drone platforms highlights how the company is seeking to extend its technology beyond automotive into civil infrastructure and public safety use cases.

• We’ll now examine how MicroVision’s reduced quarterly loss and new Avular drone collaboration interact with its existing lidar-focused investment narrative.

AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early.

MicroVision Investment Narrative Recap

To own MicroVision, you need to believe its lidar and perception software can transition from early pilots to meaningful, multi-vertical deployments across automotive, industrial, and defense uses. The smaller Q1 2026 loss and the Avular drone MoU both speak to progress, but they do not yet resolve the near term cash burn and financing risk, which still looks like the key swing factor for the stock.

The recent closure of the US$38.63 million shelf registration is particularly relevant here, because it sits directly against that financing risk. With quarterly net losses still over US$25 million and revenue at US$935,000, additional equity capacity matters for bridging the period until MOVIA S, LCAS and newer drone and defense programs can potentially scale into larger orders.

But while the technology story is expanding, investors should also be aware that financing needs and potential dilution could...

Read the full narrative on MicroVision (it's free!)

MicroVision's narrative projects $67.9 million revenue and $5.9 million earnings by 2029. This requires 195.3% yearly revenue growth and a $94.3 million earnings increase from $-88.4 million today.

Uncover how MicroVision's forecasts yield a $2.50 fair value , a 229% upside to its current price.

Exploring Other Perspectives

The most optimistic analysts once projected MicroVision’s revenue growing about 203% a year to US$73.3 million by 2028, yet the prolonged pre-revenue period and extended qualification cycles show how sharply views can differ, and Q1’s modest US$935,000 in sales plus the new drone MoU may well lead both bullish and cautious investors to revisit those assumptions.